tirzepatide compared to semaglutide clinical trial vs. for Obesity Semaglutide Safely Improves Metabolic Health – Tirzepatide versus Semaglutide Weight Loss

Published Tuesday in The New England Journal of Medicine, the Phase 3 TRANSCEND trial confirms that setmelanotide (IMCIVREE) produced a placebo-adjusted BMI reduction of nearly 20 percentage points over 52 weeks, establishing peer-reviewed evidence for the first and only FDA-approved drug targeting acquired hypothalamic obesity

You don't need more discipline

As Ozempic use grows, so do reports of possible mental health side effects As Ozempic use grows, so do reports of possible mental health side effects Nearly three months into taking Ozempic for diabetes, Jenny Kent had already lost 12 pounds, and her blood sugar numbers were looking better than they had in a while

These nutrients stimulate the L-cells to activate naturally over time